Table 2 Characteristics of RA patients
From: Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Parameters (mean ± SD) | RA patients |
|---|---|
Positive RF, n (%) | 65 (54.28%) |
Positive Anti-CCP-2 Ab, n (%) | 83 (69.57%) |
Current DMARDs therapy, n (%) | 105 (87.5%) |
Current steroid therapy, n (%) | 95 (79.4%) |
Tender joints count (n) | 16.6 ± 8.8 |
Swollen joints count (n) | 9.8 ± 5.6 |
DAS28 | 4.18 ± 1.73 |
Pain VAS score | 51.25 ± 20.09 |
HAQ score | 1.6 ± 0.64 |